Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 27, 2021	Mar. 28, 2021	Jun. 28, 2020	Mar. 29, 2020	Jun. 27, 2021	Jun. 28, 2020
Cash flows from operating activities:
Net income (loss)	$ 206,340	$ 259,144	$ (92,217)	$ 69,695	$ 465,484	$ (22,522)
Adjustments to reconcile Net income (loss) to Net cash provided by operating activities:
Depreciation and amortization					81,323	95,454
Amortization of deferred loan origination costs					40,089	33,796
Amortization of financing origination fees					7,224	6,661
Provision for long-term employee benefits					13,366	15,704
Employee benefit plan contributions and payments					(11,055)	(3,678)
Stock compensation expense					23,340	4,568
Net change in wholesale finance receivables related to sales					(129,819)	166,049
Provision for credit losses	16,201		91,179		(6,273)	170,598
Deferred income taxes					12,732	(19,461)
Other, net					(2,065)	(7,756)
Changes in current assets and liabilities:
Accounts receivable, net					(124,738)	(15,747)
Finance receivables – accrued interest and other					9,691	(2,985)
Inventories, net					58,366	163,700
Accounts payable and accrued liabilities					196,606	10,664
Other					10,029	15,158
Total adjustments					178,816	632,725
Net cash provided by operating activities					644,300	610,203
Cash flows from investing activities:
Capital expenditures					(37,568)	(67,026)
Origination of finance receivables					(2,294,500)	(1,869,569)
Collections on finance receivables					1,944,364	1,785,698
Other investing activities					2,425	(381)
Net cash used by investing activities					(385,279)	(151,278)
Cash flows from financing activities:
Repayments of medium-term notes					(1,400,000)	(1,400,000)
Proceeds from securitization debt					597,411	2,064,450
Repayments of securitization debt					(664,685)	(369,613)
Repayments of asset-backed commercial paper					(143,256)	(143,306)
Net (decrease) increase in unsecured commercial paper					(262,452)	831,354
Net increase in credit facilities					84	150,000
Net increase in deposits					179,329	17,995
Dividends paid					(46,209)	(61,917)
Repurchase of common stock					(10,911)	(7,156)
Issuance of common stock under share-based plans					4,324	41
Net cash (used) provided by financing activities					(1,746,365)	2,703,637
Effect of exchange rate changes on cash, cash equivalents and restricted cash					(6,878)	(382)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		3,409,168		$ 905,366	3,409,168	905,366
Net increase (decrease) in cash, cash equivalents and restricted cash					(1,494,222)	3,162,180
Cash, cash equivalents and restricted cash, end of period	1,914,946		$ 4,067,546		1,914,946	$ 4,067,546
HDMC Entities
Cash flows from financing activities:
Proceeds from securitization debt					0
HDFS Entities
Cash flows from financing activities:
Proceeds from securitization debt					597,411
Reportable Legal Entities | HDMC Entities
Cash flows from operating activities:
Net income (loss)	254,331				423,384
Adjustments to reconcile Net income (loss) to Net cash provided by operating activities:
Depreciation and amortization					76,749
Amortization of deferred loan origination costs					0
Amortization of financing origination fees					344
Provision for long-term employee benefits					13,366
Employee benefit plan contributions and payments					(11,055)
Stock compensation expense					21,550
Net change in wholesale finance receivables related to sales					0
Provision for credit losses	0				0
Deferred income taxes					6,505
Other, net					(2,092)
Changes in current assets and liabilities:
Accounts receivable, net					(427,762)
Finance receivables – accrued interest and other					0
Inventories, net					58,366
Accounts payable and accrued liabilities					182,066
Other					8,615
Total adjustments					(73,348)
Net cash provided by operating activities					350,036
Cash flows from investing activities:
Capital expenditures					(36,104)
Origination of finance receivables					0
Collections on finance receivables					0
Net cash used by investing activities					(33,679)
Cash flows from financing activities:
Repayments of medium-term notes					0
Repayments of securitization debt					0
Repayments of asset-backed commercial paper					0
Net (decrease) increase in unsecured commercial paper					0
Net increase in credit facilities					0
Net increase in deposits					0
Dividends paid					(46,209)
Repurchase of common stock					(10,911)
Issuance of common stock under share-based plans					4,324
Net cash (used) provided by financing activities					(52,796)
Effect of exchange rate changes on cash, cash equivalents and restricted cash					(6,217)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		666,161			666,161
Net increase (decrease) in cash, cash equivalents and restricted cash					257,344
Cash, cash equivalents and restricted cash, end of period	923,505				923,505
Reportable Legal Entities | HDFS Entities
Cash flows from operating activities:
Net income (loss)	72,464				162,474
Adjustments to reconcile Net income (loss) to Net cash provided by operating activities:
Depreciation and amortization					4,574
Amortization of deferred loan origination costs					40,089
Amortization of financing origination fees					6,880
Provision for long-term employee benefits					0
Employee benefit plan contributions and payments					0
Stock compensation expense					1,790
Net change in wholesale finance receivables related to sales					0
Provision for credit losses	16,201				(6,273)
Deferred income taxes					6,597
Other, net					(347)
Changes in current assets and liabilities:
Accounts receivable, net					0
Finance receivables – accrued interest and other					9,691
Inventories, net					0
Accounts payable and accrued liabilities					313,178
Other					5,145
Total adjustments					381,324
Net cash provided by operating activities					543,798
Cash flows from investing activities:
Capital expenditures					(1,464)
Origination of finance receivables					(4,254,353)
Collections on finance receivables					3,774,683
Other investing activities					0
Net cash used by investing activities					(481,134)
Cash flows from financing activities:
Repayments of medium-term notes					(1,400,000)
Repayments of securitization debt					(664,685)
Repayments of asset-backed commercial paper					(143,256)
Net (decrease) increase in unsecured commercial paper					(262,452)
Net increase in credit facilities					84
Net increase in deposits					179,329
Dividends paid					(120,000)
Repurchase of common stock					0
Issuance of common stock under share-based plans					0
Net cash (used) provided by financing activities					(1,813,569)
Effect of exchange rate changes on cash, cash equivalents and restricted cash					(661)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		2,743,007			2,743,007
Net increase (decrease) in cash, cash equivalents and restricted cash					(1,751,566)
Cash, cash equivalents and restricted cash, end of period	991,441				991,441
Consolidating Adjustments
Cash flows from operating activities:
Net income (loss)	(120,455)				(120,374)
Adjustments to reconcile Net income (loss) to Net cash provided by operating activities:
Depreciation and amortization					0
Amortization of deferred loan origination costs					0
Amortization of financing origination fees					0
Provision for long-term employee benefits					0
Employee benefit plan contributions and payments					0
Stock compensation expense					0
Net change in wholesale finance receivables related to sales					(129,819)
Provision for credit losses	0				0
Deferred income taxes					(370)
Other, net					374
Changes in current assets and liabilities:
Accounts receivable, net					303,024
Finance receivables – accrued interest and other					0
Inventories, net					0
Accounts payable and accrued liabilities					(298,638)
Other					(3,731)
Total adjustments					(129,160)
Net cash provided by operating activities					(249,534)
Cash flows from investing activities:
Capital expenditures					0
Origination of finance receivables					1,959,853
Collections on finance receivables					(1,830,319)
Other investing activities					0
Net cash used by investing activities					129,534
Cash flows from financing activities:
Repayments of medium-term notes					0
Proceeds from securitization debt					0
Repayments of securitization debt					0
Repayments of asset-backed commercial paper					0
Net (decrease) increase in unsecured commercial paper					0
Net increase in credit facilities					0
Net increase in deposits					0
Dividends paid					120,000
Repurchase of common stock					0
Issuance of common stock under share-based plans					0
Net cash (used) provided by financing activities					120,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash					0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		$ 0			0
Net increase (decrease) in cash, cash equivalents and restricted cash					0
Cash, cash equivalents and restricted cash, end of period	$ 0				$ 0